<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR1304.html">Part 1304
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 1304.24  Records for maintenance treatment programs and
                            </h3>
                            <p class="depth1"><em>(a)</em> Each person registered or authorized (by Sec. 1301.22 of this  chapter) to maintain and/or detoxify controlled substance users in a  narcotic treatment program shall maintain records with the following  information for each narcotic controlled substance:</p><p class="depth2"><em>(1)</em> Name of substance;</p><p class="depth2"><em>(2)</em> Strength of substance;</p><p class="depth2"><em>(3)</em> Dosage form;</p><p class="depth2"><em>(4)</em> Date dispensed;</p><p class="depth2"><em>(5)</em> Adequate identification of patient (consumer);</p><p class="depth2"><em>(6)</em> Amount consumed;</p><p class="depth2"><em>(7)</em> Amount and dosage form taken home by patient; and</p><p class="depth2"><em>(8)</em> Dispenser's initials.</p><p class="depth1"><em>(b)</em> The records required by paragraph (a) of this section will be  maintained in a dispensing log at the narcotic treatment program site  and will be maintained in compliance with Sec. 1304.22 without  reference to Sec. 1304.03.</p><p class="depth1"><em>(c)</em> All sites which compound a bulk narcotic solution from bulk  narcotic powder to liquid for on-site use must keep a separate batch  record of the compounding.</p><p class="depth1"><em>(d)</em> Records of identity, diagnosis, prognosis, or treatment of any  patients which are maintained in connection with the performance of a  narcotic treatment program shall be confidential, except that such  records may be disclosed for purposes and under the circumstances  authorized by part 310 and 42 CFR part 2.  [39 FR 37985, Oct. 25, 1974. Redesignated and amended at 62 FR 13961,  Mar. 24, 1997]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
